ID

26223

Beschreibung

Study ID: 101468/125 Clinical Study ID: SKF-101468/125 Study Title: A double-blind, multicentre, flexible dose, L-dopa controlled study of ropinirole to investigate A) neuroprotective effect as measured by 3D PET scanning, and B) ophthalmological safety, in patients with early Parkinson’s disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Stichworte

Versionen (1)
  1. 12.10.17 12.10.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

12. Oktober 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 3 Week 2 (optional visit)

Englisch

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 3 Week 2 (optional visit)

1 Formulare  
Vital signs
Beschreibung

Vital signs

Sitting blood pressure (systolic)
Beschreibung

Sitting blood pressure (systolic)

Datentyp

integer

Maßeinheiten
  • mmHg
mmHg
Sitting blood pressure (diastolic)
Beschreibung

Sitting blood pressure (diastolic)

Datentyp

integer

Maßeinheiten
  • mmHg
mmHg
Sitting Heart Rate
Beschreibung

Sitting Heart Rate

Datentyp

integer

Maßeinheiten
  • beats/min
beats/min
Concomitant medication
Beschreibung

Concomitant medication

Concomitant medication
Beschreibung

Record any change in the patient´s concomitant medication since the last visit in the Concomitant Medication section towards the back of this module.

Datentyp

text

Adverse Experiences
Beschreibung

Adverse Experiences

Adverse Experiences
Beschreibung

Have there been any adverse experiences observed or elicited by the following direct question to the patient: "Have you felt different in any way since your last visit"? Transcribe any ongoing Baseline Adverse Experiences recorded on page 10, record any changes to ongoing Baseline Adverse Experiences section towards the back of this module.

Datentyp

text

Study Medication Compliance
Beschreibung

Study Medication Compliance

Record the date on which the patient started to take study medication in the space provided at the top of page 18. Has the patient been compliant with study medication? (Compliance is defined as taking between approximately 80%-120% of medication)
Beschreibung

Study Medication Compliance

Datentyp

boolean

Patient continuation
Beschreibung

Patient continuation

Remind the patient of the date and time of their next visit.
Beschreibung

Patients continuing

Datentyp

boolean

Complete the Patient Continuation/Withdrawal section at the back of this module.
Beschreibung

Patients withdrawing

Datentyp

boolean

Zum Seitenanfang zurückkehren

Ähnliche Modelle

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 3 Week 2 (optional visit)

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Vital signs
Sitting blood pressure (systolic)
Item
Sitting blood pressure (systolic)
integer
Sitting blood pressure (diastolic)
Item
Sitting blood pressure (diastolic)
integer
Sitting Heart Rate
Item
Sitting Heart Rate
integer
Item Group
Concomitant medication
Concomitant medication
Item
Concomitant medication
text
Item Group
Adverse Experiences
Adverse Experiences
Item
text
Item Group
Study Medication Compliance
Study Medication Compliance
Item
Record the date on which the patient started to take study medication in the space provided at the top of page 18. Has the patient been compliant with study medication? (Compliance is defined as taking between approximately 80%-120% of medication)
boolean
Item Group
Patient continuation
Patients continuing
Item
Remind the patient of the date and time of their next visit.
boolean
Patients withdrawing
Item
Complete the Patient Continuation/Withdrawal section at the back of this module.
boolean
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video